Buprenorphine Extended-Release Injection and Halobetasol
Determining the interaction of Buprenorphine Extended-Release Injection and Halobetasol and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: halobetasol topical
Brand name: Bryhali, Ultravate, Ultravate X Cream, Ultravate X Ointment, Lexette
Synonyms: Halobetasol topical
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine Extended-Release Injection-Halobetasol and Tazarotene
- Buprenorphine Extended-Release Injection-Halobetasol and tazarotene topical
- Buprenorphine Extended-Release Injection-Halobetasol Cream
- Buprenorphine Extended-Release Injection-Halobetasol Cream and Ointment
- Buprenorphine Extended-Release Injection-Halobetasol Cream and Ointment with Lactic Acid Cream
- Buprenorphine Extended-Release Injection-Halobetasol Foam
- Halobetasol-Buprenorphine implant
- Halobetasol-Buprenorphine Injection
- Halobetasol-Buprenorphine injection - Buprenex
- Halobetasol-Buprenorphine injection - Sublocade
- Halobetasol-Buprenorphine Intradermal
- Halobetasol-Buprenorphine oral/buccal